April 20, 2014 2:38 AM ET


Company Overview of Immunotope, Inc.

Company Overview

Immunotope, Inc., a clinical stage biotechnology company, develops immunotherapy products for the treatment and prevention of cancer and chronic viral infections. The company focuses on the unmet need to diagnose cancer at its earliest stages and to provide effective treatments that destroy tumors and prevent recurrence and metastasis. Its products include IMT-1012, an OCPM immunotherapeutic vaccine and a multivalent cancer therapeutic mixture of various novel antigens that targets a pathway present in tumors for the treatment of ovarian, colon, and breast cancer; and an investigational new drug application for ovarian cancer patients. The company’s clinical and preclinical programs consist ...

The Pennsylvania Biotechnology Center

3805 Old Easton Road

Doylestown, PA 18902

United States

Founded in 2002



Key Executives for Immunotope, Inc.

Iterim Chief Executive
Age: 66
Co-Founder and Executive Vice President
Co-Founder and Chief Operating Officer
Chief Executive Officer of ImmunoVaccine Technologies Inc. and President of ImmunoVaccine Technologies Inc.
Age: 63
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Molecular Matrix, Inc. United States
Centrexion Corp United States
Phyllom LLC United States
Avigen, Inc. United States
Research And Diagnostic Systems, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immunotope, Inc., please visit www.immunotope.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.